Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • upendra_35
    Senior Member
    • Apr 2010
    • 102

    qPCR validation of RNA-Seq data

    I am wondering if anyone has a good and easy way of comparing RNA-Seq data and qPCR result/validation statistically. I have seen papers comparing the microarray data and qPCR but not RNA-Seq data. Any help would be highly appreciate.
  • steven
    Senior Member
    • Aug 2009
    • 269

    #2
    Originally posted by upendra_35 View Post
    I am wondering if anyone has a good and easy way of comparing RNA-Seq data and qPCR result/validation statistically. I have seen papers comparing the microarray data and qPCR but not RNA-Seq data. Any help would be highly appreciate.
    There are papers with comparison of RNA-seq and qPCR data. Check out for instance Griffith et al, Nature Methods 2010, or Asmann et al BMC Genomics, 2009. Probably the Mortazavi et al too, and those from the Burge lab.

    Comment

    • upendra_35
      Senior Member
      • Apr 2010
      • 102

      #3
      Thanks Steven. I will check it out....

      Comment

      • malachig
        Senior Member
        • Aug 2010
        • 117

        #4
        For added convenience to people landing here ... in Griffith et al. Nature Methods. 2010 Oct;7(10):843-847 [Abstract | Full Text | PDF | Supplementary Materials] the qPCR validations are presented in Figure 2. The experiment involved qPCR validation of 192 differentially expressed exons identified in the RNA-seq data. An additional qualitative assay involving RT-PCR, gel electrophoresis and Sanger sequencing was used to validate 189 exon-skipping junctions (see Supplementary Figure 10a in the Supplementary Materials). The actual data values are available from the ALEXA-seq website here. The validation rates for the quantitative and qualitative assays were 88% and 85% respectively. The selection of targets for validation was not biased towards highly expressed exons. Actually it was biased towards lowly expressed exons that were nevertheless identified as expressed above background by RNA-seq. These likely represent minor isoforms in many cases (see Supplementary Figure 10b in the Supplementary Materials). The paper also includes direct comparison to both Affymetrix exon arrays and custom NimbleGen splicing microarrays.

        Comment

        • sindrle
          Senior Member
          • Aug 2013
          • 266

          #5
          Hi!
          In lack of more cDNA I only have 12 genes from qPCR.. I want to compare edgeR vs DESeq2 vs Cuffdiff and see which I will use based on match with qPCR:

          YES/no indicates if it is significantly changed.

          Gene qPCR edgeR DESeq2 Cuffdiff
          1 no YES no no
          2 YES YES no no
          3 no no no no
          4 YES YES no no
          5 YES no no no
          6 no no no no
          7 no no no no
          8 no no no no
          9 no no no no
          10 no no no no
          11 no no no no
          12 no no no no

          I really want to use edgeR, but is this test good enought?

          Comment

          • dpryan
            Devon Ryan
            • Jul 2011
            • 3478

            #6
            I'm not sure why you tested 8 of those since they weren't DE according to any of the programs (I assume #5 was either borderline or had a huge foldchange). Given your effective n=3 of informative genes, edgeR would seem to be in the lead. However, you haven't tested any that DESeq2 or cuffdiff uniquely called DE. BTW, making more cDNA doesn't even take an hour...

            Comment

            • sindrle
              Senior Member
              • Aug 2013
              • 266

              #7
              Yeah, actually this genes where already measured, thats why I used them, I got the message about not having cDNA, but Ill ask again tomorrow!

              How many should I aim to test from each?

              Thanks!

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, Today, 12:17 PM
              0 responses
              10 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, Yesterday, 11:41 AM
              0 responses
              11 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-20-2026, 11:10 AM
              0 responses
              23 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-13-2026, 10:26 AM
              0 responses
              37 views
              0 reactions
              Last Post SEQadmin2  
              Working...